跳转至内容
Merck
CN

SML0203

Sigma-Aldrich

iCRT14

≥98% (HPLC)

别名:

5-[[2,5-二甲基-1-(3-吡啶基)-1H-吡咯-3-基]亚甲基]-3-苯基-2,4-噻唑烷二酮

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C21H17N3O2S
分子量:
375.44
MDL编号:
UNSPSC代码:
12352200
PubChem化学物质编号:
NACRES:
NA.77

质量水平

方案

≥98% (HPLC)

表单

powder

颜色

yellow to orange

溶解性

DMSO: ≥10 mg/mL

储存温度

2-8°C

SMILES字符串

Cc1cc(\C=C2/SC(=O)N(c3ccccc3)C2=O)c(C)n1-c4cccnc4

InChI

1S/C21H17N3O2S/c1-14-11-16(15(2)23(14)18-9-6-10-22-13-18)12-19-20(25)24(21(26)27-19)17-7-4-3-5-8-17/h3-13H,1-2H3/b19-12-

InChI key

NCSHZXNGQYSKLR-UNOMPAQXSA-N

应用

iCRT14可用于Wnt /β-连环蛋白介导的细胞信号转导研究。

生化/生理作用

Wnt/β-连环蛋白途径抑制剂
iCRT14属于噻唑烷二酮类β-连环蛋白反应性转录抑制剂。它可降低散乱蛋白的水平并调节T细胞因子(TCF)与DNA的结合。 它会导致结肠癌细胞中细胞增殖和肿瘤生长减少的持续减弱。
iCRT14是一种Wnt / β-连环蛋白途径抑制剂。它是连环蛋白应答转录(CRT)报告基因的有效抑制剂,以及内源基因靶标。iCRT14还可以剂量依赖性方式破坏β-连环蛋白-TCF4的相互作用,并在结肠肿瘤细胞系中引起G0/G1 的停滞。

储存分类代码

11 - Combustible Solids

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable


历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Daiana S Sánchez et al.
Biochemical and biophysical research communications, 512(2), 170-175 (2019-03-19)
This work was aimed to determine the effect of 17β-estradiol (17βE) on cell proliferation in human renal tubular epithelial cells (HRTEC) isolated from kidneys from pediatric subjects, as well as the role of estrogen receptors involved in the 17βE proliferative
Winning WNT: race to Wnt signaling inhibitors.
Kazuhide Watanabe et al.
Proceedings of the National Academy of Sciences of the United States of America, 108(15), 5929-5930 (2011-04-01)
The S-G2 phase enriched beta-catenin/TCF complex ensures cell survival and cell cycle progression
Ding Y, et al.
Journal of Cell Science, jcs-146977 (2014)
Caihong Wang et al.
Oncoimmunology, 9(1), 1809947-1809947 (2020-09-18)
In colorectal cancer, Wnt/β-catenin signaling is often aberrantly activated and associated with a T-cell-excluded phenotype which is a major obstacle for many immunotherapies. However, the effects of Wnt/β-catenin inhibition on tumor immunity and immunotherapy remain to be elucidated. In syngeneic
Xin Wang et al.
Nature communications, 7, 10633-10633 (2016-02-05)
Cancer stem cells (CSCs) contribute to tumour heterogeneity, therapy resistance and metastasis. However, the regulatory mechanisms of cancer cell stemness remain elusive. Here we identify PCNA-associated factor (PAF) as a key molecule that controls cancer cell stemness. PAF is highly

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门